Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Jasper Therapeutics Reports First Quarter 2023 Financial
Announced Planned Development Expansion of Briquilimab in Chronic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jasper
Jasper Therapeutics Appoints David Hinds as Senior Vice
REDWOOD CITY, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Jasper…
Jasper Therapeutics Presents Data Supporting Ongoing
<!-- Name:DistributionId Value:8751468 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Jasper Therapeutics Announces Positive Follow-up Clinical
<!-- Name:DistributionId Value:8751453 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Jasper Therapeutics Appoints Industry Veteran Vishal Kapoor
<!-- Name:DistributionId Value:8751457 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Jasper Therapeutics, Inc. Reports Inducement Grant Under
<!-- Name:DistributionId Value:8742172 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Jasper Therapeutics Announces Closing of Public Offering of
<!-- Name:DistributionId Value:8738111 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Jasper Therapeutics Announces Proposed Public Offering of
REDWOOD CITY, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as…
Jasper Therapeutics Announces New Positive Briquilimab Data
Three abstracts highlight the safety and efficacy of briquilimab combined with low-toxicity radiation conditioning to achieve full donor engraftment and leukemia disease eradication Data demonstrates that briquilimab is safe and…